GSK Investigational Site
Kettering, Ohio 45439-2201
0 studies enrolling now · 22 studies all time
What they study most
Atherosclerosis, Diabetes Mellitus, Type 2, Heart Failure, Congestive and Microalbuminuria, Hypertension, Irritable Bowel Syndrome (IBS), Irritable Colon, Neoplasms, Breast, Neoplasms, Prostate, Pulmonary Disease, Chronic Obstructive, Solid Tumours
Studies at this site
- Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level — Completed
- Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus — Completed
- Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease — Completed
- COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension — Completed
- A New Oral Treatment For Type II Diabetes Mellitus — Completed
- Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma — Completed
- The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial — Completed
- A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide. — Completed
- COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria — Stopped early
- Safety and Efficacy of Albiglutide in Type 2 Diabetes — Completed
- A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes — Completed
- Safety and Efficacy Study of Albiglutide in Type 2 Diabetes — Completed
- Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes — Completed
- A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes — Completed
- A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin — Completed
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
- Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin — Completed
- Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer — Completed
- Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy — Completed
- Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS) — Completed
- Treatment With Pazopanib for Neoadjuvant Breast Cancer — Completed
- Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath — Completed